Is Botox Safe During Pregnancy?

The short answer

The standard advice is to skip cosmetic Botox while you're pregnant. There's no formal guideline from groups like the American College of Obstetricians and Gynecologists or the American Academy of Dermatology either approving or banning it, but the conventional clinical default among OBs and dermatologists is to postpone all elective neuromodulator injections (Botox, Dysport, Xeomin, Jeuveau, Daxxify) until after delivery. This is a precautionary stance, not proof of harm: there are no controlled human studies in pregnancy, so providers err conservative for a purely elective treatment. Most will simply ask you to wait.

Why providers say wait, and what the data shows

Botulinum toxin works by blocking acetylcholine release at the nerve-muscle junction, the same signaling system that drives muscle activity throughout the body. The reassuring part is the molecule itself: it's a very large protein (about 150,000 daltons, or 150 kD) that, injected into a facial muscle at cosmetic doses, isn't expected to enter the bloodstream meaningfully or cross the placenta. A manufacturer pregnancy registry plus case reports now cover several hundred reported exposures, most in the first trimester, including women treated for chronic migraine and rare cases of actual maternal botulism. In that registry data, rates of miscarriage and birth defects fell within the ranges expected in the general population. But the numbers are still small and can't rule out a modest risk, so the honest summary is that no harm has been demonstrated, yet the evidence isn't strong enough to call an optional cosmetic procedure proven-safe. There's also no validated safe dose in pregnancy for any neuromodulator; a typical frown-line treatment runs roughly 20 to 40 units, but that's a real-world cosmetic range, not a safety threshold, and guidance treats elective injections as avoid-for-the-whole-pregnancy rather than limit-to-X-units. If you were treated very early before you knew you were pregnant, that's common and the available data is reassuring, so tell your OB rather than panic.

Breastfeeding: more reassuring, with a specific caveat

Botox during breastfeeding looks notably more favorable than during pregnancy because of how poorly it transfers into milk. The toxin's 150,000-dalton size is far above the roughly 800-dalton ceiling for meaningful passage into breast milk. In a published pilot study, onabotulinumtoxinA was undetectable in the milk of two nursing women and present only in trace amounts in five others after 40 to 92 facial units, and in documented cases of full-body maternal botulism while nursing, no toxin was detected in breast milk or the infant. International migraine guidance and lactation references (such as LactMed) consider it acceptable during breastfeeding. The caveat that's specific to injectables: the larger real-world risk isn't toxin in milk but the lidocaine or numbing agents used, or counterfeit and unverified product at a non-medical injector, so use a board-certified provider and tell them you're nursing.

Bottom line

For cosmetic use, the standard recommendation is to skip Botox while pregnant and resume after delivery, since it's elective with limited human safety data. While breastfeeding, the milk-transfer data is reassuring enough that many dermatologists consider it acceptable, though some still suggest waiting until you've weaned. Frown lines will keep; this is one of the easiest things to postpone. Talk to your OB-GYN or dermatologist about your specific situation before booking, especially if your injections are for a medical condition like chronic migraine or dystonia rather than wrinkles, where the risk-benefit math is different.